Literature DB >> 2419064

Central serous chorioretinopathy: to treat or not to treat?

J J De Laey.   

Abstract

Entities:  

Mesh:

Year:  1986        PMID: 2419064     DOI: 10.1007/bf00142365

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


× No keyword cloud information.
  33 in total

1.  Retrospective evaluation of photocoagulation for idiopathic central serous chorioretinopathy.

Authors:  W H Annesley; W S Tasman; D P Le Win; T L Tomer
Journal:  Mod Probl Ophthalmol       Date:  1974

2.  Bullous retinal detachment. An unusual manifestation of idiopathic central serous choroidopathy.

Authors:  J D Gass
Journal:  Am J Ophthalmol       Date:  1973-05       Impact factor: 5.258

3.  Treatment of central serous retinopathy. A comparative study with and without light coagulation.

Authors:  G Theodossiadis; D Tongos
Journal:  Ophthalmologica       Date:  1974       Impact factor: 3.250

4.  Current worldwide management of central serous choroidopathy.

Authors:  J A Berrocal
Journal:  Mod Probl Ophthalmol       Date:  1974

5.  Changing concept of central serous retinopathy and its treatment.

Authors:  A Wessing
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1973 May-Jun

6.  Argon and ruby laser photocoagulation of disciform macular disease.

Authors:  F A L'Esperance
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1971 May-Jun

7.  Central serous retinitis. A follow-up study.

Authors:  I Norholm
Journal:  Acta Ophthalmol (Copenh)       Date:  1969

8.  Treatment of persistent central serous retinopathy.

Authors:  R R Peabody; H C Zweng; H L Little
Journal:  Arch Ophthalmol       Date:  1968-02

9.  Long-term follow-up of central serous retinopathy.

Authors:  M Nanjiani
Journal:  Trans Ophthalmol Soc U K       Date:  1977-09

10.  Long-term follow-up of central serous chorioretinopathy.

Authors:  C M Gilbert; S L Owens; P D Smith; S L Fine
Journal:  Br J Ophthalmol       Date:  1984-11       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.